BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16465245)

  • 21. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remodeling of rat ventral prostate after castration involves heparanase-1.
    Augusto TM; Felisbino SL; Carvalho HF
    Cell Tissue Res; 2008 May; 332(2):307-15. PubMed ID: 18278514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human fibroblasts undergo oxidative stress-induced apoptosis without internucleosomal DNA fragmentation.
    Formichi P; Radi E; Battisti C; Tarquini E; Leonini A; Di Stefano A; Federico A
    J Cell Physiol; 2006 Aug; 208(2):289-97. PubMed ID: 16646085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of the epithelium during canalization of the rat ventral prostate.
    Bruni-Cardoso A; Carvalho HF
    Anat Rec (Hoboken); 2007 Oct; 290(10):1223-32. PubMed ID: 17847055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells.
    Youm YH; Yang H; Yoon YD; Kim DY; Lee C; Yoo TK
    Urol Oncol; 2007; 25(6):483-8. PubMed ID: 18047956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ability to cleave 28S ribosomal RNA during apoptosis is a cell-type dependent trait unrelated to DNA fragmentation.
    Samali A; Gilje B; Døskeland SO; Cotter TG; Houge G
    Cell Death Differ; 1997 May; 4(4):289-93. PubMed ID: 16465243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
    Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
    Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTBITC mediates cell cycle arrest and apoptosis induction in human HepG2 cells despite its rapid degradation kinetics in the in vitro model.
    Lamy E; Mersch-Sundermann V
    Environ Mol Mutagen; 2009 Apr; 50(3):190-200. PubMed ID: 19177499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
    Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
    J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo modulation of testosterone mediated alterations in apoptosis related proteins by [6]-gingerol.
    Shukla Y; Prasad S; Tripathi C; Singh M; George J; Kalra N
    Mol Nutr Food Res; 2007 Dec; 51(12):1492-502. PubMed ID: 18030663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecular mechanism for mimosine-induced apoptosis involving oxidative stress and mitochondrial activation.
    Hallak M; Vazana L; Shpilberg O; Levy I; Mazar J; Nathan I
    Apoptosis; 2008 Jan; 13(1):147-55. PubMed ID: 18058236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria.
    Bemis DL; Capodice JL; Gorroochurn P; Katz AE; Buttyan R
    Int J Oncol; 2006 Nov; 29(5):1065-73. PubMed ID: 17016636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo 5-fluorouracil-[corrected]induced apoptosis on murine thymocytes: involvement of FAS, Bax and Caspase3.
    Aquino Esperanza JA; Aguirre MV; Aispuru GR; Lettieri CN; Juaristi JA; Alvarez MA; Brandan NC
    Cell Biol Toxicol; 2008 Oct; 24(5):411-22. PubMed ID: 18266059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases.
    Sinha S; Pal BC; Jagadeesh S; Banerjee PP; Bandyopadhaya A; Bhattacharya S
    Prostate; 2006 Sep; 66(12):1257-65. PubMed ID: 16683271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells.
    Morrissey C; Brown M; O'Sullivan J; Weathered N; Watson RW; Tenniswood M
    Int J Urol; 2007 Jun; 14(6):545-51. PubMed ID: 17593102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death.
    Kanthasamy A; Anantharam V; Ali SF; Kanthasamy AG
    Ann N Y Acad Sci; 2006 Aug; 1074():234-44. PubMed ID: 17105920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J; Chervin AS; Nie A; Ducoff HS; Huang Z
    Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.